Anocca understands the complexity of T-cell biology. We have established a unique technology platform that replicates functional human cellular immunobiology and unlocks the potential of T-cell immunotherapies and vaccine strategies that leverage T-cell immunity.
Anocca’s approach and proprietary technologies deliver the means to efficiently and precisely harness and manipulate T-cell immunity, enabling a range of next-generation therapies and vaccination strategies that address unmet patient need in oncology, infectious disease and autoimmunity.
Today Anocca has a focus on delivering T-cell receptor-modified T-cell therapies (TCR-T) in oncology. Anocca is rapidly progressing a pipeline of novel therapeutic TCR-T candidates generated entirely with our own technologies towards clinical trials utilising our in-house state-of-the-art manufacturing capabilities and processes.
Location: Sweden, Södertälje
Member count: 51-200
Total raised: $110.798272M
Founded date: 2014
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 31.05.2023 | - | $36.688789... | - | finsmes.co... |
| 22.12.2022 | - | $26.546266... | - | finsmes.co... |
| 22.07.2021 | Series B | $47.563217... | - | finsmes.co... |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 31.05.2023 | Anocca rai... | - | - | - | globenewsw... |
| 31.05.2023 | Anocca Rai... | Anocca AB, a Södertälje, Swede... | Sweden | - | finsmes.co... |
| 22.12.2022 | Sweden-bas... | Södertälje-based Anocca, a ful... | biotech f... | Vishal Sin... | siliconcan... |
| 21.12.2022 | Anocca Sec... | Anocca, a Södertälje, Sweden-b... | Sweden | - | finsmes.co... |
| 02.08.2021 | Sweden’s A... | T-Cells are crucial immune cel... | funding H... | Editorial ... | siliconcan... |
| 22.07.2021 | Anocca : R... | Anocca AB, a leader in unlocki... | - | - | marketscre... |
| 22.07.2021 | Anocca Rai... | Anocca AB, a Sodertalje, Swede... | Sweden | - | finsmes.co... |
| - | Anocca AB | “Anocca | A Swedish privately ... | - | - | fastfounde... |